Brain Tumor Treatments: Less-Toxic
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Less-Toxic
Please scroll down past the trials to see pages on this site about this topic!
  Showing Treatment 1 to 25 of 360 Next 25 Location Last Updated
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Pittsburgh, PA USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Dallas, TX USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) New York, NY USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Edison, NJ USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Orlando, FL USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Chicago, IL 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Scarborough, ME USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Danville, PA USA 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Graz, Austria 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Kiel, Germany 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Hamburg, Germany 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Tel Aviv, Israel 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Milan, Italy 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Milan, Italy 09/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) San Diego, CA USA 09/30/2009
Details A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas Pittsburgh, PA USA 09/23/2009
Details Phase II Clinical Trial of Hyperbaric Oxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma Mineola, NY USA 06/18/2009
Details A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain Durham, NC USA 06/16/2009
Details A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain Charlotte, NC USA 06/16/2009
Details A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain West Palm Beach, FL USA 06/16/2009
Details Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas Bethesda, MD USA 04/22/2009
Details A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas Bethesda, MD USA 04/22/2009
Details A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas Bethesda, MD USA 04/21/2009
Details Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma Bethesda, MD USA 04/21/2009
Details A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas New York, NY USA 04/21/2009

(Relevance) Page Title - click title to go to the page!

  (0.8169)   Brain Tumor Treatments: Less-Toxic
  (0.7967)   Brain Tumor Treatments: New York
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Emerging Med Trials Matcher
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7742)   Regulus Navigator For Brain Surgery
  (0.7742)   Malignant Pediatric
  (0.7742)   Brain Tumor Treatments: Radiation
  (0.7742)   Proton Beam
  (0.7742)   Process Pituitary List
  (0.7742)   Braintmr List
  (0.7742)   Braintmr Mailing List
  (0.7742)   Braintmr List
  (0.7742)   Privacy Policy
  (0.7742)   Preferences
  (0.7742)   Preferences
  (0.7742)   Prayer and positive thoughts list
  (0.7742)   Prayer and positive thoughts list
  (0.7742)   Prayer and positive thoughts list
  (0.7742)   PNET Tumor
  (0.7742)   Pituitary Tumor Mailing Lists
  (0.7742)   Pituitary tumors
  (0.7742)   Pediatric Brain Tumors
  (0.7742)   BRAIN TUMOR TREATMENTS: The Peacock System
  (0.7742)   Tyramine Restricted Diet
  (0.7742)   PCV For Brain Tumors: Abstracts
  (0.7742)   PCV For Brain Tumors
  (0.7742)   Chat Transcript: Dr. Patel
  (0.7742)   Brain Tumor Treatments: Pennsylvania
  (0.7742)   Link to outside website
  (0.7742)   Brain Tumor Treatments: Oregon
  (0.7742)   Optic Glioma List
  (0.7742)   Chemosensitivity For Oligodendrogliomas
  (0.7742)   Oligodendroglioma Low Grade
  (0.7742)   Oligodendroglioma High Grade
  (0.7742)   Brain Tumor Treatments: Oklahoma
  (0.7742)   Brain Tumor Treatments: Ohio
  (0.7742)   Brain Tumor Treatments: Nevada
  (0.7742)   Noteworthy Treatments For Brain Tumors
  (0.7742)   Forums
  (0.7742)   Brain Tumor Treatments: New Mexico
  (0.7742)   Brain Tumor Treatments: New Jersey
  (0.7742)   Brain Tumor Treatments: New Hampshire
  (0.7742)   Recently Updated Treatments
  (0.7742)   Virtualtrials Newsletter Index
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter




Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites